Preferred Label : Deferiprone;
MeSH definition : A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD
in patients with THALASSEMIA.;
MeSH synonym : 1,2-Dimethyl-3-hydroxy-4-pyridinone; 1,2 Dimethyl 3 hydroxy 4 pyridinone; DMOHPO; 1,2-Dimethyl-3-hydroxypyrid-4-one; 1,2 Dimethyl 3 hydroxypyrid 4 one; 3-Hydroxy-1,2-dimethyl-4-pyridinone; 3 Hydroxy 1,2 dimethyl 4 pyridinone; HDMPP; 1,2-Dimethyl-3-hydroxypyridin-4-one; 1,2 Dimethyl 3 hydroxypyridin 4 one;
MeSH CAS label : 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-;
MeSH Related Number : 30652-11-0 (Deferiprone);
Wikipedia link : https://en.wikipedia.org/wiki/Deferiprone;
UNII : 2BTY8KH53L;
Origin ID : D000077543;
UMLS CUI : C0043832;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to BTNT
A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD
in patients with THALASSEMIA.
https://www.has-sante.fr/jcms/p_3149189/fr/deferiprone-lipomed
2020
false
false
false
France
deferiprone
treatment outcome
drugs, generic
insurance, health, reimbursement
iron chelating agents
iron overload
thalassemia major
administration, oral
evaluation of the transparency committee
Deferiprone
beta-Thalassemia
---
https://www.ema.europa.eu/en/medicines/human/EPAR/deferiprone-lipomed
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Deferiprone
Deferiprone
deferiprone
iron chelating agents
iron chelating agents
drugs, generic
thalassemia major
iron overload
administration, oral
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
beta-Thalassemia
---
https://www.has-sante.fr/portail/jcms/c_2893469/fr/deferiprone-arrow
2019
false
false
false
France
French
treatment outcome
evaluation of the transparency committee
pyridones
Deferiprone
---
https://www.has-sante.fr/portail/jcms/c_2842731/fr/ferriprox
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
deferiprone
iron chelating agents
thalassemia major
iron overload
drug therapy, combination
beta-Thalassemia
Deferiprone
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60508302
2012
France
summary of product characteristics
package leaflet
tablets
Deferiprone
---
https://www.ema.europa.eu/medicines/human/EPAR/Ferriprox
2011
false
United Kingdom
French
English
syndication feed
treatment outcome
drug evaluation
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug labeling
drug approval
iron chelating agents
thalassemia
administration, oral
iron overload
iron chelating agents
deferiprone
drug evaluation
summary of product characteristics
package leaflet
Deferiprone
Deferiprone
---